Compare NTST & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTST | ALMR |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2020 | 2026 |
| Metric | NTST | ALMR |
|---|---|---|
| Price | $17.51 | $25.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 5 |
| Target Price | $22.87 | ★ $35.40 |
| AVG Volume (30 Days) | ★ 1.4M | 593.7K |
| Earning Date | 10-21-2026 | 11-03-2026 |
| Dividend Yield | ★ 5.16% | N/A |
| EPS Growth | ★ 150.00 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $195,006,000.00 | N/A |
| Revenue This Year | $29.31 | $59.79 |
| Revenue Next Year | $19.25 | $39.75 |
| P/E Ratio | $145.25 | ★ N/A |
| Revenue Growth | ★ 19.79 | N/A |
| 52 Week Low | $17.00 | $21.58 |
| 52 Week High | $22.47 | $39.61 |
| Indicator | NTST | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 31.50 | 37.08 |
| Support Level | $17.10 | $23.69 |
| Resistance Level | $17.88 | $29.06 |
| Average True Range (ATR) | 0.34 | 2.90 |
| MACD | 0.02 | -0.93 |
| Stochastic Oscillator | 32.58 | 7.09 |
Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.